Sort   by:  
 Page size 
UnknownOncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.
Not available
S-EPMC3323897 | biostudies-literature
UnknownUbiquinol decreases monocytic expression and DNA methylation of the pro-inflammatory chemokine ligand 2 gene in humans.
Not available
S-EPMC3542089 | biostudies-literature
UnknownEngineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.
Not available
S-EPMC8232684 | biostudies-literature
UnknownDifferentially Expressed Gene Patterns in Ascarid-Infected Chickens of Higher- or Lower-Performing Genotypes.
Not available
S-EPMC8067266 | biostudies-literature
UnknownTribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.
Not available
S-EPMC5916959 | biostudies-literature
UnknownModulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.
Not available
S-EPMC5649276 | biostudies-literature
UnknownA novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.
Not available
S-EPMC5652799 | biostudies-literature
UnknownThe novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells.
Not available
S-EPMC4080209 | biostudies-literature
UnknownUbiquinol affects the expression of genes involved in PPARα signalling and lipid metabolism without changes in methylation of CpG promoter islands in the liver of mice.
Not available
S-EPMC3303474 | biostudies-literature
UnknownMyeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.
Not available
S-EPMC9427194 | biostudies-literature
Sort   by:  
 Page size